Invivoscribe Marketing, Author at Invivoscribe - Page 3 of 6

PRODUCTS
- Reagents
  ASRs
  Enzymes
  Hi-Di Formamide
- 2024 Product & Service Catalogs
CLINICAL LAB SERVICES
- Clinical Lab Services Overview
  The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.
  EXPLORE SERVICES ⟶
- Flow Cytometry
  Hematolymphoid Screening Panel
  AML MRD Assay
  CLL MRD Assay
- Companion Diagnostic (CDx) Tests
  CDx – USA
  CDx – Germany
  CDx – Japan
- NGS Cancer Panels
  MyAML
  MyMRD
- MRD NGS Tests
  Clonality
  FLT3 ITD
  NPM1
- Clonality NGS Tests
  SHM
  IGH
  IGK
  TRG
  TRB
BIOBANK REPOSITORY
DISEASES
- Lymphoid
  Mature B-cell
  Mature T-cell
  
  Lymphoma
  Lymphoma is a cancer that starts in cells that are part of the body’s immune system. Knowing which type of lymphoma you have is important because it affects your treatment options and your outlook (prognosis).
  
  LEARN MORE ⟶
- Myeloid
  Myelodysplastic Syndromes (MDS)
  Acute Myeloid Leukemia (AML)
  Myeloproliferative Neoplasms (MPNs)
  
  Myeloma
  Multiple myeloma is a cancer of plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the immune system.
  
  LEARN MORE ⟶
- Hematological Testing Menu
  Browse our comprehensive menu of product & testing services.
  EXPLORE MENU ⟶
PARTNERSHIPS
- Partnerships Overview
  A proven strategy to accelerate drug approvals
  EXPLORE PARTNERSHIPS ⟶
  CE-IVD
  LeukoStrat products are used worldwide to determine the mutation status of the FLT3 and NPM1 biomarkers.
  LEARN MORE ⟶
- Product Development
  Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays
  EXPLORE ⟶
  CE-IVD
  IdentiClone assays are intended for PCR-based detection of clonal gene rearrangements and translocations.
  LEARN MORE ⟶
- Manufacturing
  cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents
  EXPLORE ⟶
- LabPMM®
  Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment
  EXPLORE ⟶
- Global Regulatory Expertise
  Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)
  EXPLORE ⟶
SCIENCE
- Science Overview
  We take pride in expanding the science that bridges personalized medicine with quality healthcare.
  EXPLORE OUR SCIENCE ⟶
- Personalized Medicine
  Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.
  EXPLORE PERSONALIZED MEDICINE ⟶
PUBLICATIONS
- Featured Publication
  Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia
  VIEW PUBLICATION ⟶
- Latest Publications
  Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia
  VIEW PUBLICATION ⟶
  Assessment of Bone Marrow Involvement in B-Cell non-Hodgkin Lymphoma Using Immunoglobulin Gene Rearrangement Analysis with Next-Generation Sequencing
  VIEW PUBLICATION ⟶
  Evaluation of Next-Generation Sequencing Versus Next-Generation Flow Cytometry for Minimal Residual Disease Detection in Chinese Patients with Multiple Myeloma
  VIEW PUBLICATION ⟶
COMPANY
- Company
  About Us
  Our Mission, Vision & Values
  Leadership Team
  Board of Directors
  Legal Notices
  Newsroom
  Global Distributors
  Licensure and Certifications
  Careers & Culture
  Shop Corporate Gear
- Invivoscribe Locations
  
  Invivoscribe, Inc. (USA)
  San Diego, CA, US
  CONTACT US ⟶
  
  Invivoscribe, SARL (France)
  Marseille, France
  CONTACT US ⟶
  
  Invivoscribe Diagnostic Technologies,(Shanghai) Co.,Ltd.
  Shanghai, China
  CONTACT US ⟶
  Lymphoma
  Lymphoma is a cancer that starts in cells that are part of the body’s immune system. Knowing which type of lymphoma you have is important because it affects your treatment options and your outlook (prognosis).
  LEARN MORE ⟶
- Clinical Lab Locations
  
  LabPMM, LLC (USA)
  San Diego, CA, US
  CONTACT US ⟶
  
  LabPMM, GmbH (Germany)
  Munich, Germany
  CONTACT US ⟶
  
  LabPMM, GK (Japan)
  Kawasaki, Japan
  CONTACT US ⟶
  
  Invivoscribe Diagnostic Technologies,(Shanghai) Co.,Ltd.
  Shanghai, China
  CONTACT US ⟶
  Myeloma
  Multiple myeloma is a cancer of plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the immune system.
  LEARN MORE ⟶
- Support
  
  Invivoscribe, Inc. (USA)
  CONTACT US ⟶
  
  Invivoscribe, SARL (France)
  CONTACT US ⟶
  
  Invivoscribe Diagnostic Technologies,(Shanghai) Co.,Ltd.
  CONTACT US ⟶
  
  LabPMM, LLC (USA)
  CONTACT US ⟶
  
  LabPMM, GmbH (Germany)
  CONTACT US ⟶
  
  LabPMM, GK (Japan)
  CONTACT US ⟶
  Search for:
Search
- Search Articles & Publications
  Search for:
- Search Products & Services
  SEARCH ⟶
- Search Product Documents & IFUs
  SEARCH ⟶

About Invivoscribe Marketing

This author has not yet filled in any details.
So far Invivoscribe Marketing has created 146 blog entries.

A Streamlined Laboratory Workflow for Controlling Antibody and Reagent Lots on a 12C Flow Cytometry System

Invivoscribe Marketing2022-05-25T03:00:58-07:00July 15th, 2021|2021 Videos, 2021 Webinars, Featured Videos, Videos, Webinars|

Immunoglobulin gene rearrangement in Koreans with multiple myeloma: Clonality assessment and repertoire analysis using next-generation sequencing

Invivoscribe Marketing2022-09-07T22:31:04-07:00June 24th, 2021|2021 Publications, Featured Publications, Publications|

Assessment of MRD by NGS in Daily Clinical Management of Multiple Myeloma

Invivoscribe Marketing2022-05-25T03:00:58-07:00June 14th, 2021|2021 Videos, Featured Videos, Videos|

New Frontiers in Hematology: From CLL Tumor Precursor Cells to Tracking Disease Burden in Multiple Myeloma

Invivoscribe Marketing2022-05-25T03:00:58-07:00June 14th, 2021|2021 Videos, Featured Videos, Videos|

Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing

Invivoscribe Marketing2021-04-27T17:17:21-07:00April 20th, 2021|2021 Publications, Publications|

AMP

Validation of an NGS based assay for monitoring FLT3 ITD and TKD variants in AML subjects

Invivoscribe Marketing2021-03-05T20:49:11-08:00March 5th, 2021|2019 Posters, AMP, Posters|

AMP

Evaluation of An Alternative Fragmentation Method in High Throughput NGS Sample Testing of Minimal Residual Disease in Hematological Malignancies

Invivoscribe Marketing2021-03-05T20:44:34-08:00March 5th, 2021|2019 Posters, AMP, Posters|

AMP

Comparing DNA Extraction Methods for the LymphoTrack^® IVD TRG Assay

Invivoscribe Marketing2021-03-05T20:38:02-08:00March 5th, 2021|2019 Posters, AMP, Posters|

AMP

A Next-Generation Sequencing Based Analysis of Clonality across 39 Subjects Treated for Lymphoproliferative Disorders Reveals Matching Clones in the Diverse IGH Locus

Invivoscribe Marketing2021-03-03T23:53:52-08:00March 3rd, 2021|2019 Posters, AMP, Posters|

EHA

TRG Clonality Interrogation by CE and NGS: Bridging the Gap Between Classical and Leading Edge Technologies

Invivoscribe Marketing2021-03-03T23:55:00-08:00March 3rd, 2021|2020 Posters, EHA, Posters|

ASH

End of Treatment Peripheral Blood TCR Evaluation for Minimal Residual Disease Evaluation in Peripheral T-cell Lymphomas

Invivoscribe Marketing2021-03-03T23:40:33-08:00March 3rd, 2021|2020 Posters, ASH, Posters|

Complementary Value of MRD Assessments by NGS and MFC for the Study of Hematologic Malignancies

Invivoscribe Marketing2022-05-25T03:00:58-07:00December 1st, 2020|2020 Videos, 2020 Webinars, Videos, Webinars|

Validation and interpretation of IGH and TCR clonality testing by Ion Torrent S5 NGS for diagnosis and disease monitoring in B and T cell cancers

Invivoscribe Marketing2021-02-11T19:51:54-08:00November 25th, 2020|2020 Publications, Publications|

Classification of intestinal T‐cell receptor repertoires using machine learning methods can identify patients with coeliac disease regardless of dietary gluten status

Invivoscribe Marketing2021-02-11T19:57:34-08:00November 22nd, 2020|2020 Publications, Publications|

Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

Invivoscribe Marketing2021-02-17T18:10:07-08:00November 17th, 2020|2020 Publications, Featured Publications, Publications|

Artificial Intelligence (AI) and other Data Science Applications in Molecular Pathology

Invivoscribe Marketing2022-05-25T03:00:58-07:00November 16th, 2020|2020 Videos, Videos|

Clinical Utility of NGS in Lymphoid Malignancies including Minimal Residual Disease (MRD) testing

Invivoscribe Marketing2022-05-25T03:00:58-07:00November 16th, 2020|2020 Videos, Videos|

Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma

Invivoscribe Marketing2021-02-11T20:05:42-08:00October 30th, 2020|2020 Publications, Publications|

Plasticity of the human IgM repertoire in response to long‐term spaceflight

Invivoscribe Marketing2021-02-11T20:09:45-08:00October 13th, 2020|2020 Publications, Featured Publications, Publications|

Immune recovery in patients with mantle cell lymphoma receiving long-term ibrutinib and venetoclax combination therapy

Invivoscribe Marketing2021-02-11T20:11:02-08:00October 8th, 2020|2020 Publications, Publications|

Genetic evolution of in situ follicular neoplasia to aggressive B-cell lymphoma of germinal center subtype

Invivoscribe Marketing2021-02-11T20:13:51-08:00August 27th, 2020|2020 Publications, Publications|

Baseline VDJ clonotype detection using a targeted sequencing NGS assay: allowing for subsequent MRD assessment

Invivoscribe Marketing2021-02-11T20:26:38-08:00July 22nd, 2020|2020 Publications, Publications|

VIRTUAL EHA: Next Generation Analysis in CLL and Other Malignancies

Invivoscribe Marketing2022-05-25T03:00:59-07:00June 14th, 2020|2020 Videos, Featured Videos, Videos|

VIRTUAL EHA: Clonality analysis with NGS is the new frontier in MRD detection

Invivoscribe Marketing2022-05-25T03:00:59-07:00June 14th, 2020|2020 Videos, Featured Videos, Videos|

VIRTUAL EHA: Incorporating NGS Methods for Routine Clonality Assessment and Disease Monitoring of Lymphoid Malignancies

Invivoscribe Marketing2022-05-25T03:00:59-07:00June 14th, 2020|2020 Videos, Featured Videos, Videos|